Stock analysis · Bull Rankings model

SOLS analysis

Solstice Advanced Materials, Inc.Specialty Chemicals. Scored on the same transparent model behind the daily rankings.

SOLS
Solstice Advanced Materials, Inc. · Specialty Chemicals
FCF$195mC
Rev+9.2%B
D/E1.53D
P/E42.5xC
PEG0.64A-
55.2Score
$56.16$8.9B
1Y Target$80.43Analyst consensus · 7 analysts
5Y Target$117.76Compound horizon
10Y Target$174.68Long-dated conviction
FCF$195mTTM
C
FCF $195m — modest; watch for margin expansion
Rev+9.2%TTM YoY
B
Revenue +9.2% — at or above S&P median
D/E1.53
D
D/E 1.53 — most levered decile in Basic Materials (≈95th pctile)
P/E42.5x
C
P/E 42.5 — expensive vs Basic Materials peers (≈90th pctile)
PEG0.64
A-
PEG 0.64 — strong; Lynch's preferred zone

Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.

Quality-growth score · 55.2
Quality51.3
Growth50.0
Value65.7
Why this score
  • Cyclical growth
  • Short track record
Entry · Margin of safety
52-week rangeNear 52-week low
38% off the 12-month high
vs DCF fair value133% aboveest. fair value ~$24
What the price assumes: free cash flow compounding at ~32% a year for the next decade — vs the ~16% a year our model projects from current growth and analyst estimates.
Quality signals · context only
Gross profitability21% · Bgross profit ÷ total assets (Novy-Marx)

Model-generatedGenerated by the Bull Rankings model from this company's reported fundamentals, and checked against the figures shown above.

Why now
Specialty Chemicals · market cap $8.9b. Down 38% from 52-week high of $90.80 — deep drawdown territory. PEG 0.64 — paying under fair value for the growth rate. 7 sell-side analysts rate this a Buy with a mean 1-yr target of $80.43 (implying +43% upside).
Moat
ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
Down 38% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 43x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Horizon
1-3 yr $80.43 (7-analyst consensus) — fundamentals + valuation re-rating. 5 yr $117.76 at ~16% CAGR — compounding case rests on the competitive position widening. 10 yr $174.68 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

SOLS vs the Top Picks average

PillarSOLSBook avgDiff
Quality0.510.84-0.33
Growth0.500.84-0.34
Value0.660.78-0.13

Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.

Trend
+5.2 over 47 daily scores
From 50.0 (Jun 22) → 55.2 (now)

One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.

Analyst estimate revisions

30-day change+4.2%
90-day change+6.9%
Forward EPS estimate$3.34

Over the last 90 days, what analysts expect SOLS to earn is materially higher (+6.9%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →

Shares to buy
35
Position size
$1,966
3.9% of portfolio
Stop price
$42.12
25% below $56.16
$ at risk if stopped
$491.40
budget $500.00 · 1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Solstice Advanced Materials, Inc. (SOLS): score, valuation & FAQ

Solstice Advanced Materials, Inc. (SOLS) is a Specialty Chemicals company that scores 55.2 out of 100 on the Bull Rankings quality-growth model — a middling reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are PEG (A-), while D/E (D) rate weaker. On valuation, SOLS sits about 133% above our discounted-cash-flow fair value — the current price implies roughly 32% annual free-cash-flow growth over the next decade.

Is SOLS a good stock to buy?

Bull Rankings scores SOLS 55.2 out of 100 on its quality-growth model, which is a middling reading. That is driven by PEG (A-). A score is a quantitative screen of Solstice Advanced Materials, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does SOLS score 55.2 on Bull Rankings?

The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). SOLS earns its highest marks on PEG (A-), and is held back by D/E (D). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.

Is SOLS overvalued or undervalued?

Based on $56.16, SOLS sits about 133% above our discounted-cash-flow fair value — the current price implies roughly 32% annual free-cash-flow growth over the next decade. It trades at a 42.5x P/E (graded C). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in SOLS?

Down 38% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 43x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.

New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.

Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.

More Chemicals stocks by score

All Basic Materials rankings →

Analyze another ticker →